Skip to main content

Clinical Trials › NCT05119569

Active, Not RecruitingPhase 2

A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)

Sponsored by Hoffmann-La Roche

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
109
Target enrollment
2
U.S. states
Mar 2022
Start date
Dec 2026
Expected completion

Interventions / Treatments

FenebrutinibPlacebo

Conditions studied

Relapsing Multiple Sclerosis

Where this trial is running (2 sites)

Fullerton
Nevada1 site
Las Vegas

Participating MS centers on MS Buddy (1)

MS centers in California

Compare treatment centers near a trial site by center type, providers and trials.

View California centers

More Phase 2 trials

Browse all Phase 2 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play